These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 8864777

  • 21. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D, Koç M, Toprak A, Akpinar I, Velioğlu A, Deyneli O, Haklar G, Akalin S.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [Abstract] [Full Text] [Related]

  • 22. Effects of enalapril on serum lipoproteins in mild essential hypertension.
    Sasaki J, Arakawa K.
    Clin Ther; 1989 Sep; 11(1):38-42. PubMed ID: 2541908
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Reversible impairment of renal function associated with enalapril in a diabetic patient.
    Albareda MM, Corcoy R.
    CMAJ; 1998 Nov 17; 159(10):1279-81. PubMed ID: 9861226
    [Abstract] [Full Text] [Related]

  • 25. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC, El Aouar LM, Mill JG.
    Arq Bras Cardiol; 2000 Feb 17; 74(2):103-17. PubMed ID: 10904284
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Evaluation of the effect of enalapril in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Camarda G.
    Clin Ter; 1993 Jul 17; 143(1):19-21. PubMed ID: 8243018
    [Abstract] [Full Text] [Related]

  • 28. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W, Cymerys M, Kujawska-Luczak M, Pupek-Musialik D.
    Pol Merkur Lekarski; 2005 Mar 17; 18(105):287-90. PubMed ID: 15997634
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr 17; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 31. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors.
    Djordjević VB, Pavlović D, Pejović M, Cvetković T, Lecić N, Deljanin-Ilić M.
    Clin Nephrol; 1997 Apr 17; 47(4):243-7. PubMed ID: 9128791
    [Abstract] [Full Text] [Related]

  • 32. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV, Mozheĭko ME, Paliutin ShKh, Berezina MIu, Martsevich SIu, Shal'nova SA, Deev AD, Kutishenko NP, Alimova EV, Koniakhina IP, Semenova IuE.
    Ter Arkh; 2000 Apr 17; 72(10):82-6. PubMed ID: 11220887
    [Abstract] [Full Text] [Related]

  • 33. Effects of bunazosin on plasma glucose levels in hypertensive diabetic patients.
    Takeda N, Iwai T, Tanamura A, Nagano M.
    Clin Ther; 1989 Apr 17; 11(5):568-71. PubMed ID: 2572324
    [Abstract] [Full Text] [Related]

  • 34. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J.
    Arch Inst Cardiol Mex; 1997 Apr 17; 67(1):29-37. PubMed ID: 9221708
    [Abstract] [Full Text] [Related]

  • 35. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P, Tapia JC, Ugarte C, Pérez E, Krause P, Soto N, García de los Ríos M.
    Rev Med Chil; 1996 Sep 17; 124(9):1036-44. PubMed ID: 9197016
    [Abstract] [Full Text] [Related]

  • 36. The rationale for the choice of antihypertensive treatment in diabetic patients.
    Passa P.
    Diabete Metab; 1989 Sep 17; 15(5 Pt 2):362-6. PubMed ID: 2612720
    [No Abstract] [Full Text] [Related]

  • 37. Enalapril: benefit-to-risk ratio in hypertensive patients.
    Gomez HJ, Cirillo VJ, Smith SG.
    J Cardiovasc Pharmacol; 1990 Sep 17; 15 Suppl 3():S26-9. PubMed ID: 1691415
    [Abstract] [Full Text] [Related]

  • 38. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
    Erhard W, Lindner U, Krall H, Breitstadt A, Pfeiffer C.
    J Cardiovasc Pharmacol; 1991 Sep 17; 18 Suppl 2():S160-4. PubMed ID: 1725032
    [Abstract] [Full Text] [Related]

  • 39. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G, Bonaventura A, Romano D, Bianchi L, Fogari E, D'Angelo A, Maffioli P.
    J Clin Pharm Ther; 2014 Jun 17; 39(3):277-85. PubMed ID: 24635387
    [Abstract] [Full Text] [Related]

  • 40. [Problems in the treatment of the hypertensive diabetic patient].
    Malacco E, Magenta M, Sartini C.
    Minerva Med; 1987 Feb 28; 78(4):247-50. PubMed ID: 3561842
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.